Leishmania tropica in children: A retrospective study

Journal of the American Academy of Dermatology

Volumn 71, Issue 2, 2014, Pages 271-277

  Solomon, Michal ^a,b   Schwartz, Eli ^a,b   Pavlotsky, Felix ^a,b   Sakka, Nicole ^a   Barzilai, Aviv ^a,b   Greenberger, Shoshana ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

children; cryotherapy; intralesional; Leishmania tropica; liposomal amphotericin B; paromomycin ointment; sodium stibogluconate

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; KETOCONAZOLE; PAROMOMYCIN; STIBOGLUCONATE SODIUM;

ABDOMINAL PAIN; ADOLESCENT; ANTIMICROBIAL THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CRYOTHERAPY; DRUG EFFICACY; DRUG SAFETY; FACE; FEMALE; HOSPITALIZED CHILD; HUMAN; HYPERAMYLASEMIA; LEISHMANIA TROPICA; LEUKOPENIA; MALE; NAUSEA AND VOMITING; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN LEISHMANIASIS; SYSTEMIC THERAPY; TOPICAL TREATMENT; TREATMENT RESPONSE;

CHILDREN; CRYOTHERAPY; INTRALESIONAL; LEISHMANIA TROPICA; LIPOSOMAL AMPHOTERICIN B; PAROMOMYCIN OINTMENT; SODIUM STIBOGLUCONATE;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRAVENOUS; ADOLESCENT; AMPHOTERICIN B; ANTIMONY SODIUM GLUCONATE; CHILD; CHILD, PRESCHOOL; CRYOTHERAPY; FACIAL DERMATOSES; FEMALE; HUMANS; INFANT; INJECTIONS, INTRALESIONAL; LEISHMANIA TROPICA; LEISHMANIASIS, CUTANEOUS; MALE; PAROMOMYCIN; RETROSPECTIVE STUDIES; TRYPANOCIDAL AGENTS;

EID: 84904724998     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.12.047     Document Type: Article

References (32)

1. C.L. Jaffe, G. Baneth, Z.A. Abdeen, Y. Schlein, and A. Warburg Leishmaniasis in Israel and the Palestinian Authority Trends Parasitol 20 2004 328 332
2. Y. Schlein, A. Warburg, L.F. Schnur, S.M. Le Blancq, and A.E. Gunders Leishmaniasis in Israel: reservoir hosts, sandfly vectors and leishmanial strains in the Negev, Central Arava and along the Dead Sea Trans R Soc Trop Med Hyg 78 1984 480 484
3. R.L. Jacobson, C.L. Eisenberger, M. Svobodova, G. Baneth, J. Sztern, and J. Carvalho et al. Outbreak of cutaneous leishmaniasis in northern Israel J Infect Dis 188 2003 1065 1073
4. N.C. Hepburn Cutaneous leishmaniasis Clin Exp Dermatol 25 2000 363 370
5. S. Klaus, and S. Frankenburg Cutaneous leishmaniasis in the Middle East Clin Dermatol 17 1999 137 141 discussion 105-6
6. A.Z. Momeni, and M. Aminjavaheri Treatment of recurrent cutaneous leishmaniasis Int J Dermatol 34 1995 129 133
7. P.F. Moskowitz, and A.K. Kurban Treatment of cutaneous leishmaniasis: retrospectives and advances for the 21st century Clin Dermatol 17 1999 305 315
8. A.J. Magill, M. Grogl, R.A. Gasser Jr., W. Sun, and C.N. Oster Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm N Engl J Med 328 1993 1383 1387
9. A. Alcais, L. Abel, C. David, M.E. Torrez, P. Flandre, and J.P. Dedet Risk factors for onset of cutaneous and mucocutaneous leishmaniasis in Bolivia Am J Trop Med Hyg 57 1997 79 84
10. A. Belli, D. Garcia, X. Palacios, B. Rodriguez, S. Valle, and E. Videa et al. Widespread atypical cutaneous leishmaniasis caused by Leishmania (L.) chagasi in Nicaragua Am J Trop Med Hyg 61 1999 380 385
11. C.C. Oliveira, H.G. Lacerda, D.R. Martins, J.D. Barbosa, G.R. Monteiro, and J.W. Queiroz et al. Changing epidemiology of American cutaneous leishmaniasis (ACL) in Brazil: a disease of the urban-rural interface Acta Trop 90 2004 155 162
12. M.P. Oliveira-Neto, C. Pirmez, E. Rangel, A. Schubach, and G. Grimaldi Jr. An outbreak of American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) in a periurban area of Rio de Janeiro city, Brazil: clinical and epidemiological studies Mem Inst Oswaldo Cruz 83 1988 427 435
13. K. Weigle, and N.G. Saravia Natural history, clinical evolution, and the host-parasite interaction in New World cutaneous leishmaniasis Clin Dermatol 14 1996 433 450
14. A. Cruz, P.M. Rainey, B.L. Herwaldt, G. Stagni, R. Palacios, and R. Trujillo et al. Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate J Infect Dis 195 2007 602 608
15. A.D. Bryceson, J.D. Chulay, M. Ho, M. Mugambii, J.B. Were, and R. Muigai et al. Visceral leishmaniasis unresponsive to antimonial drugs, I: clinical and immunological studies Trans R Soc Trop Med Hyg 79 1985 700 704
16. R. Palacios, L.E. Osorio, L.F. Grajalew, and M.T. Ochoa Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimoniate for cutaneous leishmaniasis due to Leishmania Viannia species Am J Trop Med Hyg 64 2001 187 193
17. Y. Dowlati Cutaneous leishmaniasis: clinical aspect Clin Dermatol 14 1996 425 431
18. A. Shani-Adir, S. Kamil, D. Rozenman, E. Schwartz, M. Ramon, and L. Zalman et al. Leishmania tropica in northern Israel: a clinical overview of an emerging focus J Am Acad Dermatol 53 2005 810 815
19. J. el-On, S. Halevy, M.H. Grunwald, and L. Weinrauch Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study J Am Acad Dermatol 27 1992 227 231
20. J. el-On, L. Weinrauch, R. Livshin, Z. Even-Paz, and G.P. Jacobs Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride Br Med J (Clin Res Ed) 291 1985 704 705
21. O. Ozgoztasi, and I. Baydar A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey Int J Dermatol 36 1997 61 63
22. A. Ben Salah, N. Ben Messaoud, E. Guedri, A. Zaatour, N. Ben Alaya, and J. Bettaieb et al. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis N Engl J Med 368 2013 524 532
23. C. DiMaggio, L.S. Sun, C. Ing, and G. Li Pediatric anesthesia and neurodevelopmental impairments: a Bayesian meta-analysis J Neurosurg Anesthesiol 24 2012 376 381
24. N.E. Aronson, G.W. Wortmann, S.C. Johnson, J.E. Jackson, R.A. Gasser Jr., and A.J. Magill et al. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent US military experience Clin Infect Dis 27 1998 1457 1464
25. B.L. Herwaldt, and J.D. Berman Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies Am J Trop Med Hyg 46 1992 296 306
26. P. Minodier, K. Retornaz, A. Horelt, and J.M. Garnier Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients Fundam Clin Pharmacol 17 2003 183 188
27. M. Solomon, S. Baum, A. Barzilai, A. Scope, H. Trau, and E. Schwartz Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis J Am Acad Dermatol 56 2007 612 616
28. M. Solomon, F. Pavlotsky, E. Leshem, M. Ephros, H. Trau, and E. Schwartz Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica J Eur Acad Dermatol Venereol 25 2011 973 977
29. M. Solomon, F. Pavlotzky, A. Barzilai, and E. Schwartz Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers J Am Acad Dermatol 68 2013 284 289
30. G. Wortmann, M. Zapor, R. Ressner, S. Fraser, J. Hartzell, and J. Pierson et al. Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis Am J Trop Med Hyg 83 2010 1028 1033
31. US Astellas Pharma. Prescribing information for AmBisome. Available from: URL: http://www.astellas.us/docs/ambisome.pdf. Accessed May 2012.
32. M. Solomon, S. Baum, A. Barzilai, F. Pavlotsky, H. Trau, and E. Schwartz Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate J Eur Acad Dermatol Venereol 23 2009 1189 1192